Yu-Hsia Kuo
Overview
Explore the profile of Yu-Hsia Kuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin C, Hsu C, He H, Chiang W, Lin S, Huang Y, et al.
Medicine (Baltimore)
. 2022 Jul;
101(28):e29870.
PMID: 35839060
Background: Psoriatic arthritis (PSA) is a form of immune-mediated inflammatory arthritis that predominantly begins with enthesitis. Studying the gut microbiota of PSA patients may offer new insights into the pathogenesis...
2.
Yang I, Lee J, Wu P, Kuo H, Kuo Y, Huang H
Sci Rep
. 2020 Mar;
10(1):4000.
PMID: 32132577
Fibroblast-like transformation of retinal pigment epithelial (RPE) cells is a pathological feature of proliferative vitreoretinopathy (PVR) that may cause blindness. The effect of oxidative stress alone or together with transforming...
3.
Huang Y, Chen K, Lo M, Cai X, Chang L, Kuo Y, et al.
Int J Med Sci
. 2019 Jun;
16(4):576-582.
PMID: 31171909
Kawasaki disease (KD) is the most common acute coronary vasculitis to occur in children. Although we have uncovered global DNA hypomethylation in KD, its underlying cause remains uncertain. In this...
4.
Kuo H, Chen Y, Kuo Y, Ke M, Tseng Y, Wu P
Curr Eye Res
. 2017 Nov;
43(3):333-339.
PMID: 29182404
Purpose: Failure of retinal detachment surgery is most commonly due to the development of proliferative vitreoretinopathy (PVR). Everolimus is an inhibitor of mammalian target of rapamycin (mTOR), and is available...
5.
Kuo H, Chen Y, Wu P, Kuo Y
Ophthalmologica
. 2015 Feb;
233(3-4):198-203.
PMID: 25721986
Purpose: To investigate a new sustained-release formulation of dexamethasone (Ozurdex®) for inhibiting proliferative vitreoretinopathy (PVR) and its effect on the expression of retinal glial reaction and inflammation in experimental PVR...
6.
Lin C, Wang J, Ko J, Huang Y, Kuo Y, Wang F
J Am Soc Nephrol
. 2009 Dec;
21(1):124-35.
PMID: 20019166
Wnt/beta-catenin signaling mediates renal fibrosis in several model systems including diabetic nephropathy. Dickkopf-1 (DKK-1) is an endogenous inhibitor of Wnt/beta-catenin signaling, but whether DKK-1 modulates diabetic nephropathy is unknown. Here,...
7.
Lin C, Wang J, Ko J, Surendran K, Huang Y, Kuo Y, et al.
Endocrinology
. 2008 Mar;
149(6):2934-42.
PMID: 18339714
Intense mesangial cell apoptosis contributes to the pathogenesis of diabetic nephropathy. Although reactive oxygen radicals and Wnt signaling components are potent regulators that modulate renal tissue remodeling and morphogenesis, cross-talk...
8.
Lin C, Wang J, Huang Y, Kuo Y, Surendran K, Wang F
J Am Soc Nephrol
. 2006 Sep;
17(10):2812-20.
PMID: 16943306
Glomerulosclerosis and diabetic nephropathy are attributable to high glucose induction of mesangial cell apoptosis. Whereas Wnt signaling has been found to regulate renal morphogenesis and pathogenesis, the biologic role of...